Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanya V Kalin

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Expert Opinion on Therapeutic Targets|May 5, 2015
Is there potential to target FOXM1 for 'undruggable' lung cancers?Vladimir V Kalinichenko, Tanya V Kalin
Cell Cycle (Georgetown, Tex.)|January 29, 2011
Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse modelsTanya V Kalin, Vladimir Ustiyan, Vladimir V Kalinichenko
Current Stem Cell Reports|November 13, 2020
Genome Editing for Rare DiseasesArun Pradhan, Tanya V Kalin, Vladimir V Kalinichenko
Seminars in Cell & Developmental Biology|November 1, 2019
Molecular, cellular, and bioengineering approaches to stimulate lung regeneration after injuryCraig Bolte, Tanya V Kalin, Vladimir V Kalinichenko
Physiological Reviews|November 15, 2018
Building and Regenerating the Lung Cell by CellJeffrey A Whitsett, Tanya V Kalin, Yan Xu, et al.
Advances in Anatomy, Embryology, and Cell Biology|December 31, 2017
Transcription Factors Regulating Embryonic Development of Pulmonary VasculatureCraig Bolte, Jeffrey A Whitsett, Tanya V Kalin, et al.
American Journal of Respiratory Cell and Molecular Biology|July 22, 2021
Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary DiseasesOlena A Kolesnichenko, Jeffrey A Whitsett, Tanya V Kalin, et al.
Cancer Research|January 5, 2011
Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesisDavid Balli, Yufang Zhang, Jonathan Snyder, et al.
Oncotarget|December 2, 2015
Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage responseArun Pradhan, Vladimir Ustiyan, Yufang Zhang, et al.
Cancers|February 24, 2024
The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer TreatmentNawal Merjaneh, Mona Hajjar, Ying-Wei Lan, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Expert Opinion on Therapeutic Targets|May 5, 2015
Is there potential to target FOXM1 for 'undruggable' lung cancers?Vladimir V Kalinichenko, Tanya V Kalin
Cell Cycle (Georgetown, Tex.)|January 29, 2011
Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse modelsTanya V Kalin, Vladimir Ustiyan, Vladimir V Kalinichenko
Current Stem Cell Reports|November 13, 2020
Genome Editing for Rare DiseasesArun Pradhan, Tanya V Kalin, Vladimir V Kalinichenko
Seminars in Cell & Developmental Biology|November 1, 2019
Molecular, cellular, and bioengineering approaches to stimulate lung regeneration after injuryCraig Bolte, Tanya V Kalin, Vladimir V Kalinichenko
Physiological Reviews|November 15, 2018
Building and Regenerating the Lung Cell by CellJeffrey A Whitsett, Tanya V Kalin, Yan Xu, et al.
Advances in Anatomy, Embryology, and Cell Biology|December 31, 2017
Transcription Factors Regulating Embryonic Development of Pulmonary VasculatureCraig Bolte, Jeffrey A Whitsett, Tanya V Kalin, et al.
American Journal of Respiratory Cell and Molecular Biology|July 22, 2021
Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary DiseasesOlena A Kolesnichenko, Jeffrey A Whitsett, Tanya V Kalin, et al.
Cancer Research|January 5, 2011
Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesisDavid Balli, Yufang Zhang, Jonathan Snyder, et al.
Oncotarget|December 2, 2015
Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage responseArun Pradhan, Vladimir Ustiyan, Yufang Zhang, et al.
Cancers|February 24, 2024
The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer TreatmentNawal Merjaneh, Mona Hajjar, Ying-Wei Lan, et al.
Pageof 8